General MedicationsINJECTIONStandard
TZIELD
TEPLIZUMAB-MZWV
Standard Dose
2MG/2ML(1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview TZIELD is listed in Drugs@FDA under application 761183 (BLA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient TEPLIZUMAB-MZWV Form and strength INJECTABLE;INJECTION - 2MG/2ML(1MG/ML) Sponsor PROVENTION BIO INC Submission history Latest submission status date: 2022-11-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview TZIELD is listed in Drugs@FDA under application 761183 (BLA). Review priority: PRIORITY Marketing status: Prescription Active ingredient TEPLIZUMAB-MZWV Form and strength INJECTABLE;INJECTION - 2MG/2ML(1MG/ML) Sponsor PROVENTION BIO INC Submission history Latest submission status date: 2022-11-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.